Abstract
The term ‘eicosanoid’ was introduced by Corey et al. [1] and comprises a large and complex family of compounds derived from 20-carbon polyunsaturated fatty acids, among which arachidonic acid is the most biologically relevant. This group of substances includes prostaglandins, thromboxanes, leukotrienes, hydroperoxy- and hydroxyeicosatetraenoic acids (HPETEs and HETEs), hepoxilins, lipoxins, triox-ilins, nonleukotriene dihydroxyeicosatetraenoic acids (DiHETEs) and isoprostanes.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Corey EJ, Albright JO, Barton AE, Hashimoto S (1980) Chemical and enzymatic synthesis of 5-HPETE, a key biological precursor of slow-reacting substance of anaphylax-is (SRS) and 5-HETE. J Am Chem Soc 102: 1435–1436
Yamamoto S (1992) Mammalian lipoxygenases: molecular structures and functions. Biochim Biophys Acta 1128: 117–131
Pace-Asciak CR, Asotra S (1989) Biosynthesis, catabolism and biological properties of HPETEs, hydroperoxide derivatives of arachidonic acid. Free Radic Biol Med 7: 409–433
Porter NA (1980) Prostaglandin endoperoxides. In: WA Pryor (ed): Free radicals in biology, vol 4. Academic Press, London, 261–294
Serhan CN, Romano M (1995) Lipoxin biosynthesis and actions: role of the human platelet LX-synthase. J Lipid Mediat Cell Signal 12: 293–306
Pace-Asciak CR, Reynaud D, Demin PM (1995) Hepoxilins: a review on their enzymatic formation, metabolism and chemical synthesis. Lipids 30: 107–114
Musser JH, Kreft AF (1992) 5-Lipoxygenase: properties, pharmacology and the quino-linyl(bridged)aryl class of inhibitors. J Med Chem 35: 2501–2524
Ford-Hutchinson AW, Gresser M, Young RN (1994) 5-Lipoxygenase. Annu Rev Biochem 63: 383–417
Denzlinger C (1996) Biology and pathophysiology of leukotrienes. Crit Rev Oncol Hematol 23: 167–223
Hill E, Maclouf J, Murphy RC, Henson PM (1992) Reversible membrane association of neutrophil 5-lipoxygenase is accompanied by retention of activity and a change in substrate specificity. J Biol Chem 207: 22048–22053
Claesson H-E, HaeggstrÖm JZ, Odlander B, Medina JF, Wetterholm A, Jakobsson P-J, Radmark O (1991) The role of leukotriene A4 hydrolase in cells and tissues lacking 5-lipoxygenase. Adv Exp Med Biol 314: 307–315
Lam BK, Penrose JF, Xu K, Austen KF (1995) Leukotriene C4 synthase. J Lipid Mediat Cell Signal 12: 333–341
Brain SD, Camp RDR, Dowd PM, Black KA, Woollard PM, Mallet AI, Greaves MW (1982) Psoriasis and leukotriene B4. Lancet 2: 762–763
Brain S, Camp R, Dowd P, Black KA, Greaves M (1984) The release of leukotriene B4-like material in biologically active amounts from the lesional skin of patients with psoriasis. J Invest Dermatol 83: 70–73
Brain SD, Camp RDR, Cunningham FM, Dowd PM, Greaves MW, Black KA (1984) Leukotriene B4-like material in scale of psoriatic lesions. Br J Pharmacol 83: 313–317
Ruzicka T, Simmet T, Peskar BA, Ring J (1986) Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol 86: 105–108
Grabbe J, Rosenbach T, Czarnetzki BM (1985) Production of LTB4-like chemotactic arachidonate metabolites from human keratinocytes. J Invest Dermatol 85: 527–530
Solá J, Godessart N, Vila L, Puig L, De Moragas JM (1992) Epidermal cell-polymor-phonuclear leukocyte cooperation in the formation of leukotriene B4 by transcellular biosynthesis. J Invest Dermatol 98: 333–339
Iversen L, Fogh K, Ziboh VA, Kristensen P, Schmedes A, Kragballe K (1993) Leukotriene B4 formation during human neutrophil keratinocyte interactions: evidence for transformation of leukotriene A4 by putative keratinocyte leukotriene A4 hydrolase. J Invest Dermatol 100: 293–298
Breton J, Woolf D, Young P, Chabot-Fletcher M (1996) Human keratinocytes lack the components to produce leukotriene B4. J Invest Dermatol 106: 162–167
Ford-Hutchinson AW (1991) FLAP: a novel drug target for inhibiting the synthesis of leukotrienes. Trends Pharmacol Sci 12: 68–70
Ziboh VA, Wong T, Wu MC, Yunis AA (1986) Lipoxygenation of arachidonic acid by differentiated and undifferentiated human promyelocytic HL-60 cells. J Lab Clin Med 108: 161–166
Goerig M, Habenicht AJR, Zeh W, Salbach P, Kommerell B, Rothe DER, Nastainczyk W, Glomset JA (1988) Evidence for coordinate, selective regulation of eicosanoid synthesis in platelet-derived growth factor-stimulated 3T3 fibroblasts and in HL-60 cells induced to differentiate into macrophages or neutrophils. J Biol Chem 263: 19384–19391
Kargman S, Rouzer CA (1989) Studies on the regulation, biosynthesis and activation of 5-lipoxygenase in differentiated HL60 cells. J Biol Chem 264: 13313–13320
Bennett CF, Chiang MY, Monia BP, Crooke ST (1993) Regulation of 5-lipoxygenase and 5-lipoxygenase-activating protein expression in HL-60 cells. Biochem J 289: 33–39
Reid GK, Kargman S, Vickers PJ, Mancini JA, Leveille C, Ethier D, Miller DK, Gillard JW, Dixon RAF, Evans JF (1990) Correlation between expression of 5-lipoxy-genase-activating protein, 5-lipoxygenase and cellular leukotriene synthesis. J Biol Chem 265: 19818–19823
Janssen-Timmen U, Vickers PJ, Wittig U, Lehmann WD, Stark H-J, Fusenig NE, Rosen-bach T, Radmark O, Samuelsson B, Habenicht AJR (1995) Expression of 5-lipoxygenase in differentiating human skin keratinocytes. Proc Natl Acad Sci USA 92: 6966–6970
Sala A, Testa T, Folco G (1996) Leukotriene A4, and not leukotriene B4, is the main 5-lipoxygenase metabolite released by bovine leukocytes. FEBS Lett 388: 94–98
Sala A, Bolla M, Zarini S, Müller-Peddinghaus R, Folco G (1996) Release of leukotriene A4 versus B4 from human polymorphonuclear leukocytes. J Biol Chem 271: 17944–17948
Lindgren JA, Edenius C (1993) Transcellular biosynthesis of leukotrienes and lipoxins via leukotriene A4 transfer. Trends Pharmacol Sci 14: 351–354
Marcus AJ, Hajjar DP (1993) Vascular transcellular signalling. J Lipid Res 34: 2017–2031
Brady HR, Papayianni A, Serhan CN (1994) Leukocyte adhesion promotes biosynthesis of lipoxygenase products by transcellular routes. Kidney Int 45: S90–S97
Odlander B, Jakobsson PJ, Medina JF, Radmark O, Yamaoka KA, Rosen A, Claesson HE (1989) Formation and effects of leukotriene B4 in human lymphocytes. Int J Tissue React 11: 277–289
Jakobsson PJ, Odlander B, Claesson HE (1991) Effects of monocyte-lymphocyte interactions on the synthesis of leukotriene B4. Eur J Biochem 196: 395–400
Maugeri N, Evangelista V, Celardo A, Dell’Elba G, Martelli N, Piccardoni P, De Gae-tano G, Cerletti C (1994) Polymorphonuclear leukocyte-platelet interaction: role of P-selectin in thromboxane and leukotriene C4 cooperative synthesis. Thromb Haemost 72: 450–456
Feinmark SJ, Cannon PJ (1987) Vascular smooth muscle cell leukotriene C4 synthesis: requirement for transcellular leukotriene A4 metabolism. Biochim Biophys Acta 922: 125–135
Fukai F, Suzuki Y, Ohtaki H, Katayama T (1993) Rat hepatocytes generate peptide leukotrienes from leukotriene A4. Arch Biochem Biophys 305: 378–384
Radmark O, Shimizu T, JÖrnvall H, Samuelsson B (1984) Leukotriene A4 hydrolase in human leukocytes. Purification and properties. J Biol Chem 259: 12339–12345
Maycock AL, Anderson MS, DeSousa DM, Kuehl FA Jr (1982) Leukotriene A4: preparation and enzymatic conversion in a cell-free system to leukotriene B4. J Biol Chem 257: 13911–13914
Jakschik BA, Kuo CG (1983) Characterization of leukotriene A4 and B4 biosynthesis. Prostaglandins 25: 767–782
Iversen L, Ziboh VA, Shimizu T, Ohishi N, Radmark O, Wetterholm A, Kragballe K (1994) Identification and subcellular localization of leukotriene A4-hydrolase activity in human epidermis. J Dermatol Sci 7: 191–201
Ikai K, Okano H, Horiguchi Y, Sakamoto Y (1994) Leukotriene A4 hydrolase in human skin. J Invest Dermatol 102: 253–257
Iversen L, Kristensen P, Nissen JB, Merrick WC, Kragballe K (1955) Purification and characterization of leukotriene A4 hydrolase from human epidermis. FEBS Lett 358: 316–322
Agarwal R, Raza H, Allyn DL, Bickers DR, Mukhtar H (1992) Glutathione-S-trans-ferase-dependent conjugation of leukotriene A4-methyl ester to leukotriene C4-methyl ester in mammalian skin. Biochem Pharmacol 44: 2047–2053
Iversen L, Kristensen P, Gron B, Ziboh VA, Kragballe K (1994) Human epidermis transforms exogenous leukotriene A4 into peptide leukotrienes: possible role in transcellular metabolism. Arch Dermatol Res 286: 261–265
Keppler D (1992) Leukotrienes: biosynthesis, transport, inactivation and analysis. Rev Physiol Biochem Pharmacol 121: 1–30
KÖnig W, SchÖnfeld W, Raulf M, KÖller J, Scheffer J, Brom J (1990) The neutrophil and leukotrienes — role in health and disease. Eicosanoids 3: 1–22
Powell WS (1984) Properties of leukotriene B4 20-hydroxylase from polymorphonuclear leukocytes. J Biol Chem 259: 3082–3089
Soberman RJ, Harper TW, Murphy RC, Austen KF (1985) Identification and functional characterization of leukotriene B4 20-hydroxylase of human polymorphonuclear leukocytes. Proc Natl Acad Sci USA 82: 2292–2295
Kikuta Y, Kusunose E, Kondo T, Yamamoto S, Kinoshita H, Kusunose M (1994) Cloning and expression of a novel form of leukotriene B4 ω-hydroxylase from human liver. FEBS Lett 348: 70–74
Jedlitschky G, Huber M, VÖlkl A, Muller M, Leier I, Müller J, Lehmann WD, Fahimi HD, Keppler D (1991) Peroxisomal degradation of leukotrienes by β-oxidation from the ω-end. J Biol Chem 266: 24763–24772
Huber M, Müller J, Leier I, Jedlitschky G, Ball HA, Moore KP, Taylor GW, Williams R, Keppler D (1990) Metabolism of cysteinyl leukotrienes in monkey and man. Eur J Biocbem 194: 309–315
Wheelan P, Zirrolli JA, Morelli JG, Murphy RC (1993) Metabolism of leukotriene B4 by cultured human keratinocytes. Formation of glutathione conjugates and dihydro metabolites. J Biol Chem 268: 25439–25448
Yokomizo T, Ogawa Y, Uozumi N, Kume K, Izumi T, Shimizu T (1996) cDNA cloning, expression and mutagenesis study of leukotriene B4 12-hydroxydehydrogenase. J Biol Chem 271-: 2844–2850
Powell WS, Gravelle F (1989) Metabolism of leukotriene B4 to dihydro and dihydro-oxo products by porcine leukocytes. J Biol Chem 264: 5364–5369
Smith WL, DeWitt DL (1996) Prostaglandin endoperoxide H synthase-1 and-2. Adv Immunol 62: 167–215
Goppelt-Struebe M (1995) Regulation of prostaglandin endoperoxide synthase (cyclooxygenase) isozyme expression. Prostaglandins Leukot Essent Fatty Acids 52: 213–222
Wu KK (1996) Cyclooxygenase 2 induction: molecular mechanism and pathophysio-logic roles. J Lab Clin Med 128: 242–245
Laneuville O, Breuer DK, Xu N, Huang ZH, Gage DA, Watson JT, Lagarde M, DeWitt DL, Smith WL (1995) Fatty acid substrate specificities of human prostaglandin endoperoxide H synthases-1 and-2. Formation of 12-hydroxy-(9Z,13EJZ,15Z)-octadecatri-enoic acids from α-linoleic acid. J Biol Chem 270: 19330–19336
Meade EA, Smith WL, DeWitt DL (1993) Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem 268: 6610–6614
Masferrer JL, Zweifel BS, Manning PT, Hauser SD, Leahy KM, Smith WG, Isakson PC, Seibert K (1994) Selective inhibition of inducible cyclooxygenase 2 in vivo is anti-inflammatory and nonulcerogenic. Proc Natl Acad Sci USA 91: 3288–3232
HammarstrÖm S, Lindgren JÅ, Marcelo C, Duell EA, Anderson TF, Voorhees JJ (1979) Arachidonic acid transformations in normal and psoriatic skin. J Invest Dermatol 73: 180–183
Holtzman MJ, Turk J, Pentland A (1989) A regiospecific monooxygenase with novel stereopreference is the major pathway for arachidonic acid oxygenation in isolated epidermal cells. J Clin Invest 84: 1446–1453
Kondoh H, Sato Y, Kanoh H (1985) Arachidonic acid metabolism in cultured mouse keratinocytes. J Invest Dermatol 85: 64–69
Kvedar JC, Levine L (1987) Modulation of arachidonic acid metabolism in a cultured newborn rat keratinocyte cell line. J Invest Dermatol 88: 124–129
Pentland AP, Needleman P (1986) Modulation of keratinocyte proliferation in vitro by endogenous prostaglandin synthesis. J Clin Invest 77: 246–251
Pentland AP, Mahoney MG (1990) Keratinocyte prostaglandin synthesis is enhanced by IL-1. J Invest Dermatol 94: 43–46
Cameron GS, Baldwin JK, Jasheway DW, Patrick KE, Fisher SM (1990) Arachidonic acid metabolism varies with the state of differentiation in density gradient-separated mouse epidermal cells. J Invest Dermatol 94: 292–296
Ujihara M, Horiguchi Y, Ikai K, Urade Y (1988) Characterization and distribution of prostaglandin D synthase in rat skin. J Invest Dermatol 90: 448–451
Needleman P, Turk J, Jakschik BA, Morrison AR, Lefkowith JB (1986) Arachidonic acid metabolism. Ann Rev Biochem 55: 69–102
Weissmann G (1993) Prostaglandins as modulators rather than mediators of inflammation. J Lipid Mediat 6: 275–286
Miller WS, Ruderman FR, Smith JG Jr (1967) Aspirin and ultraviolet light-induced erythema in man. Arch Dermatol 95: 357–358
Snyder DS (1976) Effect of topical indomethacin on UVR-induced redness and prostaglandin E levels in sunburned guinea pig skin. Prostaglandins 11: 631–643
Black AK, Fincham N, Greaves MW, Hensby CN (1980) Time course changes in levels of arachidonic acid and prostaglandins D2, E2 and F2α in human skin following ultraviolet B irradiation. Br J Clin Pharmacol 10: 453–457
Ruzika T, Walter JF, Printz MP (1983) Changes in arachidonic acid metabolism in UV-irradiated hairless mouse skin. J Invest Dermatol 81: 300–303
Nagayo K (1982) Role of prostaglandin E2 and F2α in UVB-induced erythema. Jap J Derm Soc 91: 645–652
Imokawa G, Tejima T (1989) A possible role of prostaglandins in PUVA-induced inflammation: implication by organ cultured skin. J Invest Dermatol 91: 296–300
Hanson D, DeLeo V (1990) Long-wave ultraviolet light induces phospholipase activation in cultured human epidermal keratinocytes. J Invest Dermatol 95: 158–163
DeLeo VA, Horlick H, Hanson D, Eisenger M, Harber L (1984) Ultraviolet radiation induces changes in membrane metabolism of human keratinocytes in culture. J Invest Dermatol 83: 323–326
Grewe M, Trefzer U, Ballhorn A, Gyufko K, Henninger H, Krutmann J (1993) Analysis of the mechanism of ultraviolet (UV) B radiation-induced prostaglandin E2 synthesis by human epidermoid carcinoma cells. J Invest Dermatol 101: 528–531
Ashendel CL, Boutwell R, K (1979) Prostaglandin E and F levels in mouse epidermis are increased by tumor-promoting phorbol ester. Biochem Biophys Res Commun 90: 623–627
Fürstenberger G, deBravo M, Bertsch S, Marks F (1979) The effect of indomethacin on cell proliferation induced by chemical and mechanical means in mouse epidermis in vivo. Res Commun Chem Pathol Pharmacol 24: 533–541
Fürstenberger G, Marks F (1978) Indomethacin inhibition of cell proliferation induced by the phorbol ester TPA is reversed by prostaglandin E2 in mouse epidermis in vivo. Biochem Biophys Res Commun 84: 1103–1111
Blacker KL, Williams ML, Goldyne ME (1986) 6-Ketoprostaglandin F1α is a marker for keratinocyte-fibroblast interactions. J Invest Dermatol 86: 464
Scholz K, Fürstenberger G, Müller-Decker K, Marks F (1995) Differential expression of prostaglandin-H synthase isoenzymes in normal and activated keratinocytes in vivo and in vitro. Biocbem J 309: 263–
Müller-Decker K, Scholz K, Marks F, Fürstenberger G (1995) Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis. Mol Carcinog 12: 31–41
Maldve RE, Fischer SM (1996) Multifactor regulation of prostaglandin H synthase-2 in murine keratinocytes. Mol Carcinog 17: 207–216
Mestre JR, Subbaramaiah K, Sacks PG, Schantz SP, Tanabe T, Inoue H, Dannenberg AJ (1997) Retinoids suppress phorbol ester-mediated induction of cyclooxygenase-2. Cancer Res 57: 1081–1085
Hamberg M, Samuelsson B (1967) Oxygenation of unsaturated fatty acids by the vesicular gland of sheep. J Biol Chem 242: 5344–5354
Camp RDR, Mallet AI, Woollard PM, Brain SD, Kobza Black A, Greaves MW (1983) The identification of hydroxy fatty acids in psoriatic skin. Prostaglandins 26: 431–447
Baer AN, Costello PB, Green FA (1990) Free and esterified 13 (R,S)-hydroxyoctadeca-dienoic acids: principal oxygenase products in psoriatic skin scales. J Lipid Res 31: 125–130
Baer AN, Costello P, Green FA (1991) Stereospecificity of the products of the fatty acid oxygenases derived from psoriatic scales. J Lipid Res 32: 341–347
Buchanan MR, Haas TA, Lagarde M, Guichardant M (1985) 13-Hydroyoctadeca-dienoic acid is the vessel wall chemorepellant factor, LOX. J Biol Chem 260: 16056–16059
Iversen L, Fogh K, Bojesen G, Kragballe K (1991) Linoleic acid and dihomogammali-nolenic acid inhibit leukotriene B4 formation and stimulate the formation of their 15-lipoxygenase products by human neutrophils in vitro. Evidence of formation of anti-inflammatory compounds. Agents Actions 33: 286–291
Ku G, Thomas CE, Akeson AL, Jackson RL (1992) Induction of interleukin lβ expression from human peripheral blood monocyte-derived macrophages by 9-hydroxy-octadecadienoic acid. J Biol Chem 267: 14183–14188
Yamaja Setty BN, Berger M, Stuart MJ (1987) 13-Hydroxyoctadecadienoic acid (13-HODE) stimulates prostacyclin production by endothelial cells. Biochem Biophys Res Comm 146: 502–509
Bandyopadhyay GK, Imagawa W, Wallace D, Nandi S (1987) Linoleate metabolites enhance the in vitro proliferative response of mouse mammary epithelial cells to epidermal growth factor. J Biol Chem 262: 2750–2756
Glasgow WC, Eling TE (1991) Epidermal growth factor stimulates linoleic acid metabolism in BALB/c 3T3 fibroblasts. Mol Pharmacol 38: 503–510
Glasgow WC, Afshari CA, Barrett JC, Eling TE (1992) Modulation of the epidermal growth factor mitogenic response by metabolites of linoleic and arachidonic acid in syr-ian hamster embryo fibroblasts. J Biol Chem 267: 10771–10779
Rao GN, Alexander RW, Runge MS (1995) Linoleic acid and its metabolites, hydroper-oxy-octadecadienoic acids, stimulate c-fos, c-jun and c-myc mRNA expression, mitogen activated protein kinase activation and growth in rat aortic smooth muscle cells. J Clin Invest 96: 842–846
Camacho M, Godessart N, AntÓn R, GarcÍa M, Vila L (1995) Interleukin-1 enhances the ability of cultured human umbilical vein endothelial cells to oxidize linoleic acid. J Biol Chem 270: 17279–17286
Godessart N, Camacho M, López-Belmonte J, Antón R, García M, De Moragas JM, Vila L (1996) Prostaglandin H-synthase-2 is the main enzyme involved in the biosynthesis of octadecanoids from linoleic acid in human dermal fibroblasts stimulated with IL-lβ. J Invest Dermatol 107: 726–732
Loftin CD, Eling TE (1996) Prostaglandin synthase 2 expression in epidermal growth factor-dependent proliferation of mouse keratinocytes. Arch Biochem Biophys 330: 419–429
Nugteren DH, Kivits GAA (1987) Conversion of linoleic acid and arachidonic acid by skin epidermal lipoxygenases. Biochim Biophys Acta 921: 135–141
Camacho M, Vila L (1992) Biosynthesis and esterification of 13-hydroxy-eicosate-traenoic acid into phospholipids by human epidermal cells in suspensions. J Invest Dermatol 98: 527
LÓpez S, Vila L, Breviario F, de Castellarnau C (1993) Interleukin I increases 15-hyd-roxyeicosatetraenoic acid formation in cultured human endothelial cells. Biochim Biophys Acta 1170: 17–24
Godessart N, Vila L, Puig L, de Moragas JM (1994) Interleukin-1 increases 15-hydroxy-eicosatetraenoic acid production in human dermal fibroblasts. J Invest Dermatol 102: 98–104
Morham SG, Langenbach R, Loftin CD, Tiano HF, Vouloumanos N, Jennette JC, Mahler JF, Kluckman KD, Ledford A, Lee CA et al (1995) Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse. Cell 83: 473–482
Evans CB, Pillai S, Goldyne ME (1993) Endogenous prostaglandin E2 modulates calcium-induced differentiation in human skin keratinocytes. Prostaglandins Leukot Essent Fatty Acids 49: 777–781
Leong J, Hughes-Fulford M, Rakhlin N, Habib A, Maclouf J, Goldyne ME (1996) Cyclooxygenases in human and mouse skin and cultured human keratinocytes: association of COX-2 expression with human keratinocyte differentiation. Exp Cell Res 224: 79–87
HammarstrÖm S, Hamberg M, Samuelsson B, Duell AE, Stawiski M, Voorhees JJ (1975) Increased concentrations of nonesterified arachidonic acid, 12L-hydroxy-5,8,10,14-eicosatetraenoic acid, prostaglandin E2 and prostaglandin F2α in epidermis of psoriasis. Proc Natl Acad Sci USA 72: 5130–5134
Fogh K, Kiil J, Herlin T, Ternowitz T, Kragballe K (1987) Heterogeneous distribution of lipoxygenase products in psoriatic skin lesions. Arch Dermatol Res 279: 504–511
Woollard PM (1986) Stereochemical difference between 12-hydroxy-5,8,10,14-eicosate-traenoic acid in platelets and psoriatic lesions. Biochem Biophys Res Commun 136: 169–176
Wollard PM, Cunnigham FM, Murphy GM, Camp RD, Derm FF, Greaves MW (1989) A comparison of the proinflammatory effects of 12(R)-and 12(S)-hydroxy-5,8,10,14-eicosatetraenoic acid in human skin. Prostaglandins 38: 465–471
Woollard PM, Murphy GM, Cunningham FM, Camp RDR, Greaves MW (1988) Proinflammatory effects of 12(R)-hydroxy-5,8,10,14-eicosatetraenoic acid in human skin. Br J Dermatol 118: 277
Bacon KB, Camp RDR (1990) Lipid lymphocyte chemoattractants in psoriasis. Prostaglandins 40: 603–614
Otto WR, Barr RM, Dowd PM, Wright NA, Greaves MW (1989) 12-Hydroxy-5,8,10, 14-eicosatetraenoic acid (12-HETE) does not stimulate proliferation of human neonatal keratinocytes. J Invest Dermatol 92: 683–688
Van de Sandt JJ, Bos TA, Rutten AA (1995) Epidermal cell proliferation and terminal differentiation in skin organ culture after topical exposure to sodium dodecyl sulphate. In Vitro Cell Dev Biol Anim 31: 761–766
Arenberger P, Kemeny L, Rupec R, Bieber T, Ruzicka T (1992) Langerhans cells of the human skin possess high-affinity 12(S)-hydroxyeicosatetraenoic acid receptors. Eur J Immunol 22: 2469–2472
Arenberger P, Kemény L, Ruzicka T (1992) Defect of epidermal 12(S)-hydroxyeicosate-traenoic acid receptors in psoriasis. Eur J Clin Invest 22: 235–243
Capdevila J, Yadagiri P, Manna S, Falck JR (1986) Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachi-donic acid by microsomal cytochrome P-450. Biochem Biophys Res Commun 141: 1007–1011
Honn KV, Tang DG, Gao X, Butovich IA, Liu B, Timar J, Hagmann W (1994) 12-Lipoxygenases and 12(S)-HETE: role in cancer metastasis. Cancer Metastasis Rev 13:365–396
Chen X-S, Kurre U, Jenkins NA, Copeland NG, Funk CD (1994) cDNA cloning, expression, mutagenesis of C-terminal isoleucine, genomic structure and chromosomal localizations of murine 12-lipoxygenases. J Biol Chem 269: 13979–13987
Takahashi Y, Ueda N, Yamamoto S (1988) Two immunologically and catalytically distinct arachidonate 12-lipoxygenases of bovine platelets and leukocytes. Arch Biochem Biophys 266: 613–621
Takahashi Y, Ramesh Reddy G, Ueda N, Yamamoto S, Arase S (1993) Arachidonate 12-lipoxygenase of platelet-type in human epidermal cells. J Biol Chem 268: 16443–16448
Hussain H, Shornick LP, Shannon VR, Wilson JD, Funk CD, Pentland AP, Holtzman MJ (1994) Epidermis contains platelet-type 12-lipoxygenase that is overexpressed in germinal layer keratinocytes in psoriasis. Am J Physiol 266: C243–C253
Krieg P, Kinzig A, Ress-LÖschke M, Vogel S, Vanlandingham B, Stephan M, Lehmann WD, Marks F, Fürstenberger G (1995) 12-Lipoxygenase isoenzymes in mouse skin tumor development. Mol Carcinog 14: 118–129
Van Dijk KW, Steketee K, Havekes L, Frants R, Hofker M (1995) Genomic and cDNA cloning of a novel mouse lipoxygenase gene. Biochim Biophys Acta 1259: 4–8
Funk CD, Keeney DS, Oliw EH, Boeglin WE, Brash AR (1996) Functional expression and cellular localization of a mouse epidermal lipoxygenase. J Biol Chem 271: 23338–23344
Kinzig A, Fiirstenberger G, Bürger F, Vogel S, Müller-Decker K, Mincheva A, Lichter P, Marks F, Krieg P (1997) Murine epidermal lipoxygenase (Aloxe) encodes a 12-lipoxygenase isoform. FEBS Lett 402: 162–166
AntÓn R, Abián J, Vila L (1995) Characterization of arachidonic acid metabolites through the 12-lipoxygenase pathway in human epidermis by high-performance liquid chromatography and gas chromatographyJmass spectrometry. J Mass Spectrom and Rapid Commun Mass Spectrom S169-S182
Fruteau de Laclos B, Borgeat P (1988) Conditions for the formation of the oxo derivatives of arachidonic acid from platelet 12-lipoxygenase and soybean 15-lipoxygenase. Biochim Biophys Acta 958: 424–433
Pace-Asciak CR, GranstrÖm E, Samuelsson B (1983) Arachidonic acid epoxides. Isolation and structure of two hydroxy epoxide intermediates in the formation of 8, 11, 12-and 10,11,12-trihydroxyeicosatrienoic acids. J Biol Chem 258: 6835–6840.
Pace-Asciak CR (1984) Hemoglobin-and hemin-catalyzed transformation of 12L-hydroperoxy-5,8,10,14-eicosatetraenoic acid. Biochim Biophys Acta 793: 485–488
Reynaud D, Demin P, Pace-Asciak CR (1994) Hepoxilin A3 formation in the rat pineal gland selectively utilizes (12S)-hydroperoxy-eicosatetraenoic acid (HPETE), but not (12R)-HPETE. J Biol Chem 269: 23976–23980
Vasiljeva LL, Manukina TA, Demin PM, Lapitskaja MA, Pivnitsky KK (1993) Synthesis, properties and identification of epimeric hepoxilins (-)-(10R)-B3 and (+)-(10S)-B3. Tetrahedron 49: 4099–4106
Demin PM, Pivnitsky KK, Vasiljeva LL, Pace-Asciak CR (1994) Synthesis of methyl [5,6,8,9,14,15-3H6]-hepoxilin B3 and its conversion into methyl [5,6,8,9,14,15-3H6]-hepoxilin A3. J Label Comp Radiopharm 34: 221–230
Laneuville O, Corey EJ, Couture R, Pace-Asciak CR (1991) Hepoxilin A3 increases vascular permeability in the rat skin. Eicosanoids 4: 95–97
Wang M-M, Demin PM, Pace-Asciak CR (1996) Epimer-specific actions of hepoxilins A3 and B3 on PAF-and bradykinin-evoked vascular permeability in the rat skin in vivo. Adv Exp Med Biol 416: 239–241
Van Wauwe J, Coene M-C, Van Nyen G, Cools W, Goossens J, Le Jeune L, Lauwers W, Janssen PAJ (1991) NADPH-dependent formation of 15-and 12-hydroxy-eicosatrienoic acid from arachidonic acid by rat epidermal microsomes. Eicosanoids 4: 155–163
Murphy RC, Falf JR, Lumin S, Yadagiri P, Zirrolli JA, Balazy M, Masferrer JL, Abraham NG, Schwartzman ML (1988) 12(R)-hydroxyeicosatrienoic acid: a vasodilator cytochrome P450-dependent arachidonate metabolite from the bovine corneal epithelium. J Biol Chem 263: 17197–17202
Masferrer J, Murphy RC, Pagano PJ, Dunn MW, Schwartzman ML (1989) Ocular effects of a novel cytochrome P450-dependent arachidonic acid metabolite. Invest Oph-thalmol Vis Sci 30: 454–460
Conners MS, Schwartzman ML, Quan X, Heilman E, Chauhan K, Falck JR, Godfrey HP (1995) Enhancement of delayed hypersensitivity inflammatory reactions in guinea pig skin by 12(R)-hydroxy-5,8,14-eicosatrienoic acid. J Invest Dermatol 104: 47–51
Pace-Asciak CR, Lee WS (1989) Purification of hepoxilin epoxide hydrolase from rat liver. J Biol Chem 264: 9310–9313.
Pace-Asciak CR, Laneuville O, Chang M, Reddy CC, Su WG, Corey EJ (1989) New products in the hepoxilin pathway: isolation of 11-glutathionyl hepoxilin A3 through reaction of hepoxilin A3 with glutathione S-transferase. Biochem Biophys Res Commun 163: 1230–1234
Pace-Asciak CR, Laneuville O, Su WG, Corey EJ, Gurevich N, Wu P, Carlen PL (1990). A glutathione conjugate of hepoxilin A3: formation and action in the rat central nervous system. Proc Natl Acad Sci USA 87: 3037–3041
AntÓn R, Puig L, Esgleyes T, de Moragas JM, Vila L (1998) Occurrence of hepoxilins and trioxilins in psoriatic lesions. J Invest Dermatol 110: 303–350
Capdevila JH, Karara A, Waxman DJ, Martin MV, Falck JR, Guengerich FP (1990) Cytochrome P-450 enzyme-specific control of the regio-and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase. J Biol Chem 265: 10865–10871
Garssen G J, Veldink GA, Vliegenthart JFG, Boldingh J (1976) The formation of threo- 11-hydroxy-trans-12:13-epoxy-9-cis-octadecenoic acid by enzymic isomerisation of 13-L-hydroperoxy-9-cis, 11-trans-octadecadienoic acid by soybean lipoxygenase-1. Eur J Bioehem 62: 33–36
Carroll MA, Schwartzman M, Sacerdoti D, McGiff JC (1988) Novel renal arachidonate metabolites. Am J Med Sci 295: 268–274
Rubbo H, Radi R, Trujillo M, Telleri R, Kalyanaraman B, Barnes S, Kirk M, Freeman BA (1994) Nitric oxide regulation of Superoxide and peroxynitrite-dependent lipid per-oxidation. J Biol Chem 269: 26066–26075
Laskey RE, Mathews WR (1996) Nitric oxide inhibits peroxynitrite-induced production of hydroxyeicosatetraenoic acids and F2-isoprostanes in phosphatidylcholine liposomes. Areh Bioehem Biophys 330: 192–198
Kolb-Bachofen V, Fehsel K, Michel G, Ruzicka T (1994) Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Laneet 344: 139–140
SirsjÖ A, Karlsson M, GidlÖf A, Rollman O, TÖrmä H (1996) Increased expression of inducible nitric oxide synthase in psoriatic skin and cytokine-stimulated cultured ker-atinocytes. Br J Dermatol 134: 643–648
Nigam S, Müller S, Pace-Asciak CR (1993) Hepoxilins activate phospholipase D in the human neutrophil. Dev Oncol 71, 249–252
Reynaud D, Demin P, Pace-Asciak CR (1996) Hepoxilin A3-specific binding in human neutrophils. Biochem J 313: 537–541
Dho S, Grinstein S, Corey EJ, Su WG, Pace-Asciak CR (1990) Hepoxilin A3 induces changes in cytosolic calcium, intracellular pH and membrane potential in human neutrophils. Biochem J 266: 63–68
Laneuville O, Reynaud D, Grinstein S, Nigam S, Pace-Asciak CR (1993) Hepoxilin A3inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-pheny-lalanine, platelet-activating factor and leukotriene B4. Biochem J 295: 393–397
Tuschil A, Lam C, Haslberger A, Lindley I (1992) Interleukin-8 stimulates calcium transients and promotes epidermal cell proliferation. J Invest Dermatol 99: 294–298
Pace-Asciak CR, Martin JM (1984) Hepoxilin, a new family of insulin secretagogues formed by intact rat pancreatic islets. Prostaglandins Leukot Med 16: 173–180
Pace-Asciak CR, Martin JM, Corey EJ (1986) Hepoxilins potential endogenous mediators of insulin release. Prog Lipid Res 25: 625–628
Piomelli D, Shapiro E, Feinmark SJ, Schwartz JH (1987) Metabolites of arachidonic acid in the nervous system of Aplysia: possible mediators of synaptic modulation. J Neurosci 7: 3675–3686
Pace-Asciak CR (1994) Hepoxilins: a review on their cellular actions. Biochim Biophys Acta 1215: 1–8
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer Basel AG
About this chapter
Cite this chapter
Vila, L., Antón, R., Camacho, M. (1999). Keratinocytes as a cellular source of inflammatory eicosanoids. In: Schröder, JM. (eds) Fatty Acids and Inflammatory Skin Diseases. Progress in Inflammation Research. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8761-8_7
Download citation
DOI: https://doi.org/10.1007/978-3-0348-8761-8_7
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-9762-4
Online ISBN: 978-3-0348-8761-8
eBook Packages: Springer Book Archive